Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Jubilant Appoints Director of Business Development | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Jubilant Appoints Director of Business Development

Mark Sassler charged with developing new biz strategies for company ops in Montreal and Spokane areas

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Jubilant HollisterStier has named Mark Sassler as their new director of business development for the contract manufacturing and services division. Mr. Sassler will report to Lynn Allen, senior director of sales and marketing and will be responsible for developing new business strategies for facilities located in Montreal, Quebec, Canada and Spokane, WA.
 
Mr. Sassler has more than 20 years of experience in the pharmaceutical industry. He joins the company after serving 10 years as the executive director, North America business development for Clinpak Technologies. Prior to his time at Clinpak, Mr. Sassler was responsible for new business and sales development at Bilcare Clinical Supplies, Pharmaceutics International, Inc. and Cardinal Health
 
“With his successful record of new business development and his experience in the market, Mark will play a critical role in growing Jubilant’s business. We are excited to welcome him to the Jubilant business development team,” said Ms. Allen.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters